Weekly Analysts’ Ratings Updates for Stryker (SYK)
by Kim Johansen · The Markets DailyA number of research firms have changed their ratings and price targets for Stryker (NYSE: SYK):
- 10/12/2026 – Stryker had its price target lowered by BTIG Research from $358.00 to $316.00. They now have a “buy” rating on the stock.
- 10/7/2026 – Stryker had its “market perform” rating reaffirmed by Sanford C. Bernstein.
- 10/7/2026 – Stryker was upgraded by Barclays PLC to “strong-buy”.
- 10/6/2026 – Stryker is now covered by Barclays PLC. They set an “overweight” rating and a $375.00 price target on the stock.
- 10/6/2026 – Stryker had its price target lowered by Truist Financial Corporation from $340.00 to $310.00. They now have a “hold” rating on the stock.
- 10/3/2026 – Stryker was downgraded by Wall Street Zen from “buy” to “hold”.
- 9/30/2026 – Stryker had its price target lowered by Stifel Nicolaus from $360.00 to $330.00. They now have a “buy” rating on the stock.
- 9/22/2026 – Stryker had its price target lowered by TD Cowen from $355.00 to $298.00. They now have a “hold” rating on the stock.
- 9/18/2026 – Stryker had its price target lowered by Canaccord Genuity Group Inc. from $400.00 to $385.00. They now have a “buy” rating on the stock.
- 9/10/2026 – Stryker had its price target lowered by Citigroup Inc. from $399.00 to $360.00. They now have a “buy” rating on the stock.
- 9/9/2026 – Stryker had its “outperform” rating reaffirmed by BMO Capital Markets. They now have a $317.00 price target on the stock.
- 9/9/2026 – Stryker had its price target lowered by Wells Fargo & Company from $418.00 to $348.00. They now have an “overweight” rating on the stock.
Stryker Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Wednesday, September 30th will be paid a $0.88 dividend. The ex-dividend date of this dividend is Wednesday, September 30th. This represents a $3.52 annualized dividend and a yield of 1.3%. Stryker’s payout ratio is presently 36.48%.
Insider Buying and Selling
In other Stryker news, insider Debra King sold 826 shares of the company’s stock in a transaction that occurred on Tuesday, August 18th. The stock was sold at an average price of $336.30, for a total value of $277,783.80. Following the transaction, the insider directly owned 6,210 shares of the company’s stock, valued at $2,088,423. This represents a 11.74% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Dylan Crotty sold 441 shares of the business’s stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $328.61, for a total value of $144,917.01. Following the completion of the sale, the insider directly owned 6,102 shares of the company’s stock, valued at approximately $2,005,178.22. This represents a 6.74% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last 90 days, insiders have sold 351,267 shares of company stock worth $118,197,701. 4.60% of the stock is owned by insiders.
Stryker Corporation (NYSE: SYK) is a global medical technology company that develops and manufactures products used in hospitals, surgical centers and other healthcare settings. Founded in 1941 by Dr. Homer Stryker in Kalamazoo, Michigan, the company has grown from an orthopedic device business into a diversified provider of medical technologies.
Stryker’s product portfolio includes orthopedic implants and instruments, surgical equipment, neurovascular devices, spine products, patient-handling and emergency-care equipment, operating-room systems, and digital and robotic technologies.